Bregni, G., Vandeputte, C., Pretta, A., Senti, C., Trevisi, E., Acedo Reina, E., Kehagias, P., Liberale, G., Moretti, L., Bali, M. A., Demetter, P., Flamen, P., Carrasco, J., D'Hondt, L., Geboes, K., Gokburun, Y., Peeters, M., Van den Eynde, M., Van Laethem, J., Vergauwe, P., Chapot, C. A., Buyse, M., Deleporte, A., Hendlisz, A., & Sclafani, F. (2021). rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer. Acta oncologica, 60, 549–553. http://access.bl.uk/ark:/81055/vdc_100127474710.0x000052